Company Name Calithera Biosciences
Mailing Address 343 Oyster Point Blvd. South San Francisco, CA 94080
Company Description The primary mission of Calithera Biosciences is to develop novel therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. Our first program is focused on developing activators of caspases, the proteases that induce apoptosis, for the treatment of cancer.
Proceeds Purposes Calithera will use the proceeds from the financing to accelerate the development of the company’s lead clinical-stage candidate CB-839 through Phase 1 clinical trials in patients with advanced solid and hematological tumors.